Publications by authors named "Adrian A Bot"

Claim this Profile
F
Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.
Sattva S Neelapu, Caron A Jacobson, Armin Ghobadi, David B Miklos, Lazaros J Lekakis, Adrian A Bot

Blood· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis